Clinical Trial Update: The Scandinavian Randomized Controlled Trial of Isolated Hepatic Perfusion for Uveal Melanoma Liver Metastases [Phase 3]

View source ↗

Summary

Phase 3 trial update on isolated hepatic perfusion for liver metastases from uveal melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Uveal Melanoma

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Melanoma, Uveal Neoplasms | Phase 3 | Status: COMPLETED